178 related articles for article (PubMed ID: 9376506)
21. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
Liu X; Hu J; Zhang X; Fan D
Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
[TBL] [Abstract][Full Text] [Related]
22. Cancer immunotherapy based on recombinant Salmonella enterica serovar Typhimurium aroA strains secreting prostate-specific antigen and cholera toxin subunit B.
Fensterle J; Bergmann B; Yone CL; Hotz C; Meyer SR; Spreng S; Goebel W; Rapp UR; Gentschev I
Cancer Gene Ther; 2008 Feb; 15(2):85-93. PubMed ID: 18084243
[TBL] [Abstract][Full Text] [Related]
23. Live, attenuated Salmonella typhimurium vectoring Campylobacter antigens.
Sizemore DR; Warner B; Lawrence J; Jones A; Killeen KP
Vaccine; 2006 May; 24(18):3793-803. PubMed ID: 16135393
[TBL] [Abstract][Full Text] [Related]
24. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
[TBL] [Abstract][Full Text] [Related]
25. The development of a bivalent vaccine against diarrhoeal disease.
Forrest BD
Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):449-57. PubMed ID: 2464195
[TBL] [Abstract][Full Text] [Related]
26. Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model.
Negi VD; Singhamahapatra S; Chakravortty D
Vaccine; 2007 Jul; 25(29):5315-23. PubMed ID: 17574312
[TBL] [Abstract][Full Text] [Related]
27. Expression of a Porphyromonas gingivalis hemagglutinin on the surface of a Salmonella vaccine vector.
Isoda R; Simanski SP; Pathangey L; Stone AE; Brown TA
Vaccine; 2007 Jan; 25(1):117-26. PubMed ID: 16942819
[TBL] [Abstract][Full Text] [Related]
28. Two Novel
Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
[TBL] [Abstract][Full Text] [Related]
29. [A chromosomal integration system for development of polyvalent vaccine strains].
Tu HL; Li SQ; Dong ZZ; Zhang ZS
Yi Chuan Xue Bao; 1998 Dec; 25(6):551-8. PubMed ID: 10465899
[TBL] [Abstract][Full Text] [Related]
30. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei.
Rui X; Xu Y; Wan H; Su G; Huang C
Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355
[TBL] [Abstract][Full Text] [Related]
31. [Cloning and expression of Shiga-like toxin type II variant B gene of E. coli].
Ni Z; Jiao X; Gao S; Zhang R; Liu X
Wei Sheng Wu Xue Bao; 2000 Dec; 40(6):591-7. PubMed ID: 12549052
[TBL] [Abstract][Full Text] [Related]
32. [An avirulent vibrio cholerae strain--producer of the cholera toxin B subunit: obtaining and molecular genetic analysis].
Smirnova NI; Krepostnova IM; Livanova LF; Zadnova SP; Eremin SA; Il'ina TS
Mol Gen Mikrobiol Virusol; 2007; (4):7-13. PubMed ID: 18154075
[TBL] [Abstract][Full Text] [Related]
33. The potential Salmonella aroA- vaccine strain is safe and effective in young BALB/c mice.
Burns-Guydish SM; Zhao H; Stevenson DK; Contag CH
Neonatology; 2007; 91(2):114-20. PubMed ID: 17344661
[TBL] [Abstract][Full Text] [Related]
34. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
[TBL] [Abstract][Full Text] [Related]
35. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice.
Gentschev I; Fensterle J; Schmidt A; Potapenko T; Troppmair J; Goebel W; Rapp UR
BMC Cancer; 2005 Feb; 5():15. PubMed ID: 15703070
[TBL] [Abstract][Full Text] [Related]
36. [Effects of the recombinant plasmid carrying the genes of cholera prophages CTX and RS1 on the expression of virulence and immunogenicity genes in the cholera pathogen].
Smirnov NI; Zadnova SP; Toporkov AV
Mol Gen Mikrobiol Virusol; 2005; (3):3-8. PubMed ID: 16173391
[TBL] [Abstract][Full Text] [Related]
37. Construction of plasmid vectors with a non-antibiotic selection system based on the Escherichia coli thyA+ gene: application to cholera vaccine development.
Morona R; Yeadon J; Considine A; Morona JK; Manning PA
Gene; 1991 Oct; 107(1):139-44. PubMed ID: 1720753
[TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.
Tacket CO; Kelly SM; Schödel F; Losonsky G; Nataro JP; Edelman R; Levine MM; Curtiss R
Infect Immun; 1997 Aug; 65(8):3381-5. PubMed ID: 9234801
[TBL] [Abstract][Full Text] [Related]
39. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
[TBL] [Abstract][Full Text] [Related]
40. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
